FAQ

MEDI 493

Known as: Monoclonal Antibody MEDI-493, MEDI-493, Monoclonal Antibody, MEDI-493 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2007
0119972007

Related topics

Related topics

1 relation

Broader (1)

palivizumab

Related mentions per year

Related mentions per year

1972-2018
197019801990200020102020
MEDI 493
palivizumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus.
We have identified a single tryptophan (Trp) residue responsible for loss of binding and biological activity upon ultraviolet (UV… (More)
Is this relevant?
1999
1999
A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9.
Two humanized monoclonal antibodies, MEDI-493 and RSHZ19, were developed independently as potential improvements over RSV-IGIV… (More)
Is this relevant?
1998
1998
Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group.
BACKGROUND Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection in infants. MEDI-493… (More)
Is this relevant?
1998
1998
Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. The MEDI-493 Study Group…
BACKGROUND Respiratory syncytial virus (RSV) is the leading cause of lower respiratory disease in infants and children. MEDI-493… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein.
Thirty-five children <2 years of age mechanically ventilated for respiratory syncytial virus (RSV) infection were randomized to… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.
Neutralizing polyclonal antibody to respiratory syncytial virus (RSV) has been shown to be an effective prophylactic agent when… (More)
Is this relevant?